Canada Considers Consumer Rx Ads

18 November 1996

Canada is expected to decide before year-end if prescription drugmakers should be allowed to advertise direct to the public. Health Canada conducted hearings on the issue in June.

Although such advertising is illegal in Canada, it is present because of the advertising coming across the border from the USA. Moreover, Canada does allow "peek-a-boo" advertising for prescription drugs, in which consumers are invited to call toll-free numbers for information about various conditions. The phone message may include drug advertising.

The Canadian Medical Association and the Canadian Drug Manufacturers Association, which represents the generics makers, say that if such ads are permitted, they should be reviewed by an independent third party, and the CMA also wants the "reality check" of post-marketing studies. For the research-based industry, the Pharmaceutical Manufacturers Association of Canada agrees that such ads should be subject to independent review, but also notes that a poll which it commissioned showed 72% of respondents felt consumers should be able to get drug information from the manufacturer.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight